Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access
-
Narrated by:
-
By:
About this listen
Here’s a clean, professional Show Notes section you can use:
Show Notes
In this episode, I’m joined by Sabina Hemmi, founder of GLP Winner, to break down the growing wave of federal and state legislation targeting compounded GLP-1 medications.
We discuss:
Why transparent GLP-1 pricing matters
How GLP Winner helps patients compare clinics without deceptive funnels
The federal Safe Drugs Act and emerging state bills
How some legislation could impact all compounding, not just GLP-1s
What this means for hospice care, pediatrics, veterinary medicine, and more
Why patient advocacy at the state level matters right now
The real-life side effects and lived experience behind the policy debate
If you live in a state where legislation is moving, contact your representative and share your story. Patient voices are making a difference.
Connect with Sabina
TikTok: https://www.tiktok.com/@lawliepopInstagram: https://www.instagram.com/lawliepops/YouTube: https://www.youtube.com/@lawliepopX/Twitter: https://x.com/lawliepopSubstack: https://substack.com/@lawliepopLinkedIn: https://www.linkedin.com/in/sabina-hemmi/
Resources
Visit GLP-1 Studio for the latest bill updates and advocacy tools.
Get full access to GLP-1 Studio at glp1studio.substack.com/subscribe